hibispeptins (KRIBB)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehibispeptins (KRIBB)
Drug Alias Namegastrointestinal disorder therapy (KRIBB)hibispeptin B (KRIBB)hibispeptin A (KRIBB)
ClassificationNatural product/ExtractBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVomitingFlatulenceDiarrhea +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKorean Research Institute of Bioscience and Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKorean Research Institute of Bioscience and Biotechnology
Active IndicationsN/A
Inactive IndicationsVomitingFlatulenceDiarrhea +[6] 

Other Information

ATC CodeN/A
Related LinksN/A